Enhancing Health Care Value Through Data, Measurement and Evaluation of Services and Procedures
As Americans grapple with the enormous strain of the COVID-19 pandemic on humanity and the health system, there is a clear need to adapt the health system to more efficiently address the needs of patients. Each year billions of dollars are misplaced and wasted in the system due, in part, to a lack of understanding of the value we get for money.
Evidence-based tools can help make sure money goes where it’s needed most. For decades, the field of health economics and outcomes research has designed and deployed methods to conduct clinical and economic evaluation of health interventions. These ever-evolving tools serve as an important foundation to assess value and efficiency across the health care system.
But today, there is a large imbalance in how these methods are applied. The majority focus on medicines, even though prescription drugs make up less than 15% of health care spending. Value evidence must be applied more proportionately to other parts of the health system to meaningfully lower health spending, and to do so we must acknowledge and address key barriers to more holistic evidence generation. In doing so, we can learn lessons from decades of robust generation of value evidence for medicines.
All parts of the system should be accountable for making health care affordable and high value. We solicited thought leaders to tackle barriers and provide an agenda to inform more robust evidence generation on effectiveness and value of health care services. The experts authored briefs on different topics that Health Affairs is publishing in a series of upcoming blogs through November 2021. The RC-HCVA will also host a webinar, facilitated by Dr. Mark Fendrick, in which the panel of researchers will share their findings and insights into these topics.1 There will be an opportunity for questions and answers.
|1:00 – 1:05 pm||Welcome and Housing Keeping (George Miller, Co-Director of RC-HCVA)|
|1:05 – 1:15 pm||Mark Fendrick (Co-Director of RC-HCVA and Facilitator – Introduction of today’s speakers)|
|1:15 – 1:30 pm||
Value Defects in the Health Services Sector
|1:30 – 1:45 pm||
Challenges and Barriers to Measuring Effectiveness of Health Service Interventions
|1:45 – 2:00 pm||
Challenges and Barriers to Measuring Cost of Health Service Interventions
|2:00 – 2:15 pm||
Why Are There So Few Value Assessments on Health Services and Procedures and What Should Be Done?
|2:15 – 2:30 pm||
Emerging Health Technology Assessment Methods and Evidence Generation on Patient-Driven Values in Healthcare Services
|2:30 – 2:45 pm||
A Blueprint to Advance Patient-Centered Core Impact Sets (PC-CIS)
|3:00 pm||Leveraging Community Benefit to Increase the Value of Health Care
1. The Research Consortium for Health Care Value Assessment (RC-HCVA) established the research Grant-Making Center in 2020 with support from the Pharmaceutical Research Manufacturers of America (PhRMA).
The Research Consortium for Health Care Value Assessment is a partnership between Altarum and VBID Health, with funding from the PhRMA Foundation as part of its Value Assessment Initiative, established to promote the pursuit of value in health care delivery in the U.S. Follow us at @ValueConsortium.